Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Real-world Acute Treatment Optimization for Migraine with Ubrogepant: Results from the COURAGE II Study

Author:Nahas, Stephanie   Mays, Brittany   Naccara, Nicole   Wang, Cuiwei   Contreras-De Lama, Janette   Lipton, Richard   

Session Name:P8: Headache: Acute, Rescue, and Short-term Prevention Migraine Pharmacologic Treatment  

Topic:Headache  

Program Number:P8.015  

Author Institution:Thomas Jefferson University, Philadelphia, PA  University of Pennsylvania, PA  Abbvie, Chino Hills, CA  AbbVie, IL  Albert Einstein College of Medicine, Bronx, NY  

Comparative Efficacy, Safety, and Tolerability of Atogepant and Erenumab: Indirect Treatment Comparison of the TEMPLE and HER-MES Head-to-head Trials

Author:Tepper, Stewart   Gandhi, Pranav   Ubamadu, Ifeanyi   Dabruzzo, Brett   Carr, Karen   Nagy, Krisztian   Gendolla, Astrid   Versijpt, Jan   Ailani, Jessica   

Session Name:P10: Headache: Pharmacological Migraine Prevention 2  

Topic:Headache  

Program Number:P10.002  

Author Institution:The New England Institute for Neurology and Headache, Stamford, CT  AbbVie, IL  AbbVie, Frederick, MD  AbbVie, Mettawa, IL  AbbVie, Budapest, Hungary  Praxis Gendolla, Germany  Universitair Ziekenhuis Brussel, Belgium  Medstar Georgetown Neurology, McLean, VA